BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27808061)

  • 21. Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation.
    Meyer SC; O'Meara A; Buser AS; Tichelli A; Passweg JR; Stern M
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):440-4. PubMed ID: 23089566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party.
    Penack O; Peczynski C; van der Werf S; Finke J; Ganser A; Schoemans H; Pavlu J; Niittyvuopio R; Schroyens W; Kaynar L; Blau IW; van der Velden WJFM; Sierra J; Cortelezzi A; Wulf G; Turlure P; Rovira M; Ozkurt Z; Pascual-Cascon MJ; Moreira MC; Clausen J; Greinix H; Duarte RF; Basak GW
    Front Immunol; 2020; 11():586. PubMed ID: 32351502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-transplant ferritin, albumin and haemoglobin are predictive of survival outcome independent of disease risk index following allogeneic stem cell transplantation.
    Chee L; Tacey M; Lim B; Lim A; Szer J; Ritchie D
    Bone Marrow Transplant; 2017 Jun; 52(6):870-877. PubMed ID: 28504664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum ferritin is a different predictor from transfusion history for allogeneic transplantation outcome in patients with severe aplastic anemia.
    Zhang X; Shi Y; Huang Y; Zhang G; He Y; Jiang E; Wei J; Yang D; Ma Q; Zhang R; Zhai W; Feng S; Han M
    Hematology; 2018 Jun; 23(5):291-298. PubMed ID: 29046127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron overload in allogeneic hematopoietic stem cell transplant recipients.
    Ali S; Pimentel JD; Munoz J; Shah V; McKinnon R; Divine G; Janakiraman N
    Arch Pathol Lab Med; 2012 May; 136(5):532-8. PubMed ID: 22540302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation.
    Altès A; Remacha AF; Sureda A; Martino R; Briones J; Canals C; Brunet S; Sierra J; Gimferrer E
    Bone Marrow Transplant; 2002 Jun; 29(12):987-9. PubMed ID: 12098067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of non-transferrin-bound iron (NTBI) in comparison to serum ferritin on outcome after allogeneic stem cell transplantation (ASCT).
    Hilken A; Langebrake C; Wolschke C; Kersten JF; Rohde H; Nielsen P; Kröger N
    Ann Hematol; 2017 Aug; 96(8):1379-1388. PubMed ID: 28585071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study.
    Alessandrino EP; Della Porta MG; Bacigalupo A; Malcovati L; Angelucci E; Van Lint MT; Falda M; Onida F; Bernardi M; Guidi S; Lucarelli B; Rambaldi A; Cerretti R; Marenco P; Pioltelli P; Pascutto C; Oneto R; Pirolini L; Fanin R; Bosi A
    Haematologica; 2010 Mar; 95(3):476-84. PubMed ID: 19903678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron.
    Goto T; Ikuta K; Inamoto Y; Kamoshita S; Yokohata E; Koyama D; Onodera K; Seto A; Watanabe K; Imahashi N; Tsukamoto S; Ozawa Y; Sasaki K; Ito M; Kohgo Y; Miyamura K
    Int J Hematol; 2013 Jan; 97(1):125-34. PubMed ID: 23264147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron Overload Following Hematopoietic Stem Cell Transplantation: Prevalence, Severity, and Management in Children and Adolescents with Malignant and Nonmalignant Diseases.
    Cattoni A; Capitoli G; Casagranda S; Corti P; Adavastro M; Molinaro A; Di Gennaro F; Bonanomi S; Biondi A; Galimberti S; Balduzzi A
    Transplant Cell Ther; 2023 Apr; 29(4):271.e1-271.e12. PubMed ID: 36708803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron overload in allogeneic hematopoietic cell transplantation outcome: a meta-analysis.
    Armand P; Kim HT; Virtanen JM; Parkkola RK; Itälä-Remes MA; Majhail NS; Burns LJ; DeFor T; Trottier B; Platzbecker U; Antin JH; Wermke M
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1248-51. PubMed ID: 24769316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation.
    Mahindra A; Bolwell B; Sobecks R; Rybicki L; Pohlman B; Dean R; Andresen S; Sweetenham J; Kalaycio M; Copelan E
    Br J Haematol; 2009 Aug; 146(3):310-6. PubMed ID: 19508292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refinement of the Glasgow Prognostic Score as a pre-transplant risk assessment for allogeneic hematopoietic cell transplantation.
    Shibasaki Y; Suwabe T; Katagiri T; Tanaka T; Ushiki T; Fuse K; Sato N; Yano T; Kuroha T; Hashimoto S; Narita M; Furukawa T; Sone H; Masuko M
    Int J Hematol; 2018 Sep; 108(3):282-289. PubMed ID: 29744806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes.
    Artz AS; Logan B; Zhu X; Akpek G; Bufarull RM; Gupta V; Lazarus HM; Litzow M; Loren A; Majhail NS; Maziarz RT; McCarthy P; Popat U; Saber W; Spellman S; Ringden O; Wickrema A; Pasquini MC; Cooke KR;
    Haematologica; 2016 Nov; 101(11):1426-1433. PubMed ID: 27662010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased Hepatic Iron Content Predicts Poor Survival in Patients With Iron Overload Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation.
    Sivgin S; Baldane S; Deniz K; Zararsiz G; Kaynar L; Cetin M; Unal A; Eser B
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S10-8. PubMed ID: 27521305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfusion-associated iron overload as a predictive factor for poor stem cell mobilization in patients with haematological malignancies.
    Park IH; Kim Y; Kim JS; Cheong JW; Song JW; Min YH
    Transfus Med; 2008 Apr; 18(2):97-103. PubMed ID: 18399843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there any relationship between pulmonary function tests and post-transplant complications of allogeneic hematopoetic stem cell transplantation?
    Aydoğdu M; Ozyilmaz E; Köktürk N; Yeğin ZA; Özkurt ZN; Aki ZS; Sucak G
    Minerva Med; 2012 Jun; 103(3):189-98. PubMed ID: 22653099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of iron parameters in patients undergoing allo-SCT.
    Bazuaye GN; Buser A; Gerull S; Tichelli A; Stern M
    Bone Marrow Transplant; 2012 Jan; 47(1):60-4. PubMed ID: 21399668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of prohepcidin levels and iron parameters on early post-transplantation toxicities.
    Akı SZ; Paşaoğlu H; Yeğin ZA; Suyanı E; Demirtaş CY; Ozkurt ZN; Yağcı M; Sucak GT
    Hematology; 2011 Sep; 16(5):284-90. PubMed ID: 21902892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.